Quantitative Reverse Transcriptase Polymerase Chain Reaction and the Oncotype DX Test for Assessment of Human Epidermal Growth Factor Receptor 2 Status: Time to Reflect Again?

被引：13

作者：

Bartlett, John M. S. ^{[1
,2
]}

Starczynski, Jane ^{[1
]}

机构：

[1] Ontario Inst Canc Res, Toronto, ON, Canada

[2] Univ Edinburgh, Edinburgh Canc Res Ctr, Edinburgh, Midlothian, Scotland

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 32期

关键词：

EXTERNAL QUALITY-ASSURANCE; IN-SITU HYBRIDIZATION; HER2; UK; IMMUNOHISTOCHEMISTRY; AMPLIFICATION;

D O I：

10.1200/JCO.2011.37.5824

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：4219 / 4221

页数：3

共 16 条

[1]

[Anonymous], 2007, J CLIN ONCOL, DOI DOI 10.1200/JCO.2006.09.2775

[2]

[Anonymous], GENOMIC HLTH ONCOTYP

[3]

Human Epidermal Growth Factor Receptor 2 Assessment in a Case-Control Study: Comparison of Fluorescence In Situ Hybridization and Quantitative Reverse Transcription Polymerase Chain Reaction Performed by Central Laboratories [J].

Baehner, Frederick L. ;

Achacoso, Ninah ;

Maddala, Tara ;

Shak, Steve ;

Quesenberry, Charles P., Jr. ;

Goldstein, Lynn C. ;

Gown, Allen M. ;

Habel, Laurel A. .

JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (28) :4300-4306

[4]

The clinical evaluation of HER-2 status: which test to use? [J].

Bartlett, J ;

Mallon, E ;

Cooke, T .

JOURNAL OF PATHOLOGY, 2003, 199 (04) :411-417

[5]

Evaluating HER2 amplification and overexpression in breast cancer [J].

Bartlett, JMS ;

Going, JJ ;

Mallon, EA ;

Watters, AD ;

Reeves, JR ;

Stanton, P ;

Richmond, J ;

Donald, B ;

Ferrier, R ;

Cooke, TG .

JOURNAL OF PATHOLOGY, 2001, 195 (04) :422-428

[6]

External quality assurance of HER2 fluorescence in situ hybridisation testing: results of a UK NEQAS pilot scheme [J].

Bartlett, John M. S. ;

Ibrahim, Merdol ;

Jasani, Bharat ;

Morgan, John M. ;

Ellis, Ian ;

Kay, Elaine ;

Magee, Hilary ;

Barnett, Sarah ;

Miller, Keith .

JOURNAL OF CLINICAL PATHOLOGY, 2007, 60 (07) :816-819

[7]

Biomarkers and Patient Selection for PI3K/Akt/mTOR Targeted Therapies: Current Status and Future Directions [J].

Bartlett, John M. S. .

CLINICAL BREAST CANCER, 2010, 10 :S86-S95

[8]

External Quality Assurance of HER2 FISH and ISH Testing Three Years of the UK National External Quality Assurance Scheme [J].

Bartlett, John M. S. ;

Ibrahim, Merdol ;

Jasani, Bharat ;

Morgan, John M. ;

Ellis, Ian ;

Kay, Elaine ;

Connolly, Yvonne ;

Campbell, Fiona ;

O'Grady, Anthony ;

Barnett, Sarah ;

Miller, Keith .

AMERICAN JOURNAL OF CLINICAL PATHOLOGY, 2009, 131 (01) :106-111

[9]

Real-Time RT-PCR Analysis for Evaluating the Her2/neu Status in Breast Cancer [J].

Cuadros, M. ;

Talavera, P. ;

Lopez, F. J. ;

Garcia-Perez, I. ;

Blanco, A. ;

Concha, A. .

PATHOBIOLOGY, 2010, 77 (01) :38-45

[10]

High False- Negative Rate of HER2 Quantitative Reverse Transcription Polymerase Chain Reaction of the Oncotype DX Test: An Independent Quality Assurance Study [J].

Dabbs, David J. ;

Klein, Molly E. ;

Mohsin, Syed K. ;

Tubbs, Raymond R. ;

Shuai, Yongli ;

Bhargava, Rohit .

JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (32) :4279-4285

← 1 2 →